Cytoplasmic extracts prepared from cells infected with metabolically radiolabeled virions of human immunodeficiency virus type 1 contain viral DNA in association with labeled viral proteins. Viral DNA can be purified from these extracts by gel filtration chromatography and sucrose gradient sedimentation as a part of a nucleoprotein complex containing integrase as the only viral protein detectable by immunoprecipitation and gel electrophoretic analysis. The purified complex contains no detectable gag gene products, including p17, p24, p7, or p6, and contains no additional pol gene products, including the plO protease, p66 and p5l polymerase, or the p15 RNase H. Nearly all of the purified nucleoprotein complexes are capable of integrating into heterologous DNA targets in vitro. These observations demonstrate that integrase is a component of the human immunodeficiency virus type 1 preintegration complex and suggest that integrase may be the only viral protein necessary for the integration of retroviral DNA.
The retroviral replication cycle begins when the fusion of the viral envelope and cell membrane occurs and the virion core containing the viral RNA genome is released into the cytoplasm of the infected cell. The viral core contains all of the functions necessary for the conversion of the singlestranded RNA genome into a linear, double-stranded DNA molecule (15) . Following its synthesis in the cytoplasm, the viral DNA intermediate migrates to the nucleus, where integration into the cellular genome establishes a proviral template for the synthesis of viral RNA. Presumably, some or all of the viral core proteins remain associated with the linear viral DNA and mediate the functions, such as nuclear localization and integration, necessary to establish the provirus.
Linear viral DNA can be isolated from the cytoplasm of infected cells as a discrete nucleoprotein complex (1, 6) . When separated from the bulk of cellular proteins, the nucleoprotein complex is capable of mediating the integration of viral DNA into heterologous DNA targets in vitro, suggesting that these complexes may contain all of the functions necessary for viral integration (2, 6) . Little is known about the structure or composition of the cytoplasmic preintegration complex. Here, the viral proteins associated with fully integration-competent human immunodeficiency type 1 (HIV-1) DNA purified from the cytoplasm of newly infected cells are characterized.
MATERIALS AND METHODS
Cells and viruses. The chronically HIV-1-infected Molt IIIB human T-cell line (HTLV-IIIB strain) was the source of virus for cell-free infections. Virus production from the cells was stimulated approximately 10-fold by incubation with phorbol esters. To prepare 3H-labeled virions, 108 Molt IIIB cells were cultured for 20 h in arginine-free RPMI 1640 medium containing 20% fetal calf serum, 10 ng of phorbol 12-myristate 13- Preparation of cell extracts. SupTl cells (50 x 108 cells) were infected with concentrated, 3H-labeled virus (300 to 500 ng of p24 viral core protein per ml) in 25 ml of RPMI 1640 medium containing 10% fetal calf serum. Cytoplasmic extracts (1.2-ml volume) were prepared from cells 4 to 5 h postinfection as previously described (6) and treated with RNase A (20 ,ug/ml) for 30 min at room temperature. Triton X-100 (Sigma) was added to a final concentration of 0.5% to extracts before fractionation by gel filtration. Cell extracts from uninfected SupTl cells were prepared in the same manner, except that they were not treated with RNase A prior to the addition of detergent.
Sephacryl S400 chromatography. Cytoplasmic extracts (0.8 ml) were loaded onto a 22-ml Sephacryl S400 (Pharmacia) column, 28 cm in height, equilibrated in buffer K (20 mM HEPES [N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid], pH 7.4, 150 mM KCI, 5 mM MgCl2, 1 mM dithiothreitol, 25 mM aprotinin) containing 0.5% Triton X-100 at 4°C. Fractions (0.5 ml) were collected at a flow rate of approximately 0.2 ml/min. Sucrose gradient sedimentation. S400 column fractions containing viral DNA were pooled, and 1.5 ml was layered onto 12-ml gradients of 15 to 30% sucrose in buffer K-0.5% Triton X-100 and centrifuged at 35,000 rpm for 3 h at 4°C in a Beckman SW41 rotor. Fractions (1 ml) were collected from the bottom of the gradient.
Analysis of viral proteins. Proteins were analyzed by immunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). For immunoprecipitations, cytoplasmic extracts, S400 column fractions, and sucrose gradient fractions were adjusted to 1% Triton X-100, and sodium deoxycholate and SDS were added to final concentrations of 1 and 0.1%, respectively. Antiserum (5 to 10 ,ul) was added and incubated for 12 Triton X-100, and 0.1% SDS and once in the same buffer minus detergents. Proteins were analyzed by electrophoresis on 10 to 18% polyacrylamide gradient gels containing SDS followed by fluorography.
Immunoprecipitation of viral DNA. S400 column fractions containing the peak of viral DNA were pooled, and 0.75 ml was incubated with 10 ,ul of antiserum for 1 h at 4°C with occasional gentle mixing. The Sepharose beads were allowed to settle at unit gravity, the supernatant was collected for the analysis of viral DNA (see below), and the beads were washed three times in a buffer K-0.5% Triton X-100 at 4°C in the same manner. Immunoprecipitated viral DNA was recovered by suspending the Sepharose beads in buffer K and extracting the DNA as described below.
Analysis of viral DNA. Viral DNA was recovered from cytoplasmic extracts, S400 column fractions, sucrose gradient fractions, and immunoprecipitation supernatants and pellets by SDS-proteinase K treatment and phenol extraction as previously described (6) . Agarose gel electrophoresis and Southern blotting and hybridization analyses of viral DNA were performed as previously described (6) .
Preparation of rabbit antiserum against trpE-integrase fusion protein. A fusion protein of the HIV-1 integrase and the Escherichia coli trpE protein was expressed in bacteria by using a plasmid vector provided by Steven Goff. Growth of bacteria, induction of the trp operon, and preparation of bacterial extracts were as described previously (14) . Cytoplasmic extracts of cells infected with the labeled virus were fractionated by gel filtration chromatography.
The methods used for preparation of the cell extracts and chromatography were those previously demonstrated to yield functional preintegration complexes (6) . The cytoplasmic extracts were fractioned on a Sephacryl S400 column. The column fractions were analyzed for the presence of viral DNA by Southern blot analysis using an HIV-1-specific probe. The Southern blot analysis showed that DNA eluted near the void volume, well separated from the peak of cellular proteins (Fig. 1B and data not shown).
Viral proteins cofractionating with the linear viral DNA were analyzed by immunoprecipitation and SDS-PAGE analysis of column fractions by using an HIV-1-positive human serum. This serum recognized all of the viral gag and pol gene products (Fig. 1A, lane 1) . The identities of the immunoreactive viral proteins were confirmed by using polyclonal antisera raised to purified individual HIV-1 proteins (see below). Three viral proteins, p17, p24, and the integrase p31, eluted in or near the void volume of the column (Fig. 1A, fractions 16 (Fig. 2, lane 1) . Neither of these cross-reacting viral proteins is present in the column fractions containing viral DNA (Fig.   2, lanes 2 to 5) . The p51 form of the viral polymerase is not recognized by this antiserum.
Human polyclonal immunoglobulin G reactive with HIV-1 reverse transcriptase recognized the envelope glycoprotein gpl20, the p66 and pS1 viral DNA polymerase, and the p31 integrase in the unfractionated extracts, consistent with previous reports (8) (Fig. 2, lane 6 ). 3, and 7) . Likewise, a polyclonal antiserum to the uncleaved precursor of p7 and p6, the p159a9 protein, recognized small proteins having molecular weights expected of the viral nucleocapsid proteins from unfractionated extracts but failed to detect these proteins in the column fractions containing viral DNA (lanes 5 and 6).
Cytoplasmic extracts were treated with RNase A prior to gel filtration in order to ensure that the void volume fractions did not contain viral RNA in association with viral proteins derived from the infecting virions. Cytoplasmic extracts were also prepared from cells infected with 3H-labeled virus 30 min postinfection, at a time when linear viral DNA is not detectable (6) . The 30-min extract was treated with RNase A and fractionated by Sephacryl S400 chromatography. Void volume fractions were analyzed for viral DNA and protein.
Neither viral DNA nor integrase protein was detectable in the void volume fractions, even though labeled viral proteins were readily detectable in the included volume fractions of the column (data not shown).
The ability of the linear viral DNA eluted from the column to integrate into target DNA molecules in vitro was determined. The assay used to detect the integration activity was that previously described, integration of viral DNA into a linearized 4OX174 DNA target (6) . The junction formed between viral DNA and target sequences in vitro is identical to that observed in infected cells. Joining of viral DNA occurs at the highly conserved 5'-TG/CA-3' sequences present at the ends of the linear viral DNA, and a 5-bp direct repeat of target DNA sequences flanks the integrated provirus (9) . In the physical assay, integration is detected by the shift of linear viral DNA on Southern blots into a highermolecular-weight form (6) . Figure 1C, 5) and human polyclonal immunoglobulin G to HIV-1 reverse transcriptase (see text for a description of this antiserum) (lanes 6 to 10). Lanes 1 and 6, Immunoprecipitated proteins from 0.3 ml of unfractionated cytoplasmic extract; lanes 2 to 5 and 7 to 10, immunoprecipitation of S400 column fractions 17 to 20, respectively.
of the viral DNA molecules have integrated into target after a 1-h incubation. The integration efficiency of the viral DNA in column fractions was indistinguishable from that of viral DNA in the unfractionated extracts (Fig. 1C, lane 1) . Addition of a cytoplasmic extract from uninfected SupTl cells to the column fractions containing viral DNA has no effect on the extent or rate of integration of viral DNA (Fig. 1C, lane 3).
Sucrose gradient sedimentation. To verify that integrase protein which eluted in the void volume of the column was associated with viral DNA, fractions containing the peak of viral DNA and integrase were analyzed by sucrose gradient sedimentation. Figure 4C shows the Southern blot detection of viral DNA in fractions collected from a 15 to 30% sucrose gradient. Viral DNA eluted from the Sephacryl S400 column migrated with a sedimentation profile similar to that of viral DNA present in unfractionated cell extracts. The gradient fractions containing viral DNA also contained integrase protein as detected by immunoprecipitation and SDS-PAGE analysis ( Fig. 4A and B, lane 3) , indicating an association between these two viral components. Gradient fractions containing the peak of viral DNA and integrase contained no p17 or p24 detectable by immunoprecipitation with polyclonal sera to p17 and p24 proteins (Fig. 4B, lanes 1 and 2) . The viral DNA present in the sucrose gradient fractions was fully competent for integration in vitro (Fig. 4C, lanes 5' and  6 '), indicating that no component necessary for the in vitro integration reaction was lost by this additional step of purification.
Immunoprecipitation of viral DNA with antiserum to integrase. If the 31-kDa integrase protein is tightly bound to the proviral DNA, as suggested by coelution from the Sephacryl column and by cosedimentation on the sucrose gradient, it should be possible to precipitate viral DNA with antiserum to the 31-kDa integrase protein. To examine this possibility, several antisera to HIV-1 proteins were tested for the ability to immunoprecipitate viral DNA from column fractions. Viral DNA was found only in the supernatants of immunoprecipitation reactions when antiserum to capsid protein p17 or p24 was used (Fig. 5, lanes 5 and 7) . However, full-length linear proviral DNA was detected in the precipitated fractions when antiserum to the 31-kDa integrase protein was used (Fig. 5, lanes 1 and 2) . Deproteinated viral DNA was not precipitated by antiserum to integrase (Fig. 5, lanes 11 and 12). 
DISCUSSION
The viral integrase protein was shown to be a major component of the integration-competent nucleoprotein complex isolated from the cytoplasm of cells newly infected with HIV-1. Furthermore, integrase was the only viral protein that remained associated with the viral DNA through successive purification by gel filtration and gradient sedimentation. All other virion-associated proteins carried into the cell during infection were separated from the viral preintegration complex without affecting its ability to integrate into DNA targets in vitro. The purified complex contained no detectable gag proteins, including p17, p24, p7, and p6. The preintegration complex was similarly devoid of other pol gene products, including the p66 and pSl viral DNA polymerase proteins, the 15-kDa RNase H, and the 10-kDa viral protease. This is the first report that defines the viral proteins present in a purified, fully functional retroviral preintegration complex.
Integrase eluted in the void volume fractions of a Sephacryl S400 column by virtue of its association with newly synthesized viral DNA. This association was demonstrated by the ability of a polyclonal antiserum to HIV-1 integrase to immunoprecipitate the viral DNA from column fractions and by the comigration of integrase and viral DNA in column fractions on sucrose density gradients. The preintegration complex present in unfractionated cytoplasmic extracts and the complex purified by gel filtration had similar sucrose gradient sedimentation profiles (Fig. 4 [6] ), suggesting that gel filtration did not significantly alter the overall composition or structure of the complex. As much as 98% of the viral DNA present in column fractions and gradient fractions was able to integrate into target DNA molecules in vitro, further evidence that the fractionation procedures used did not disrupt any structural or functional features of the complex needed for integration.
The presence of integrase in a retroviral preintegration complex is not surprising, given the genetic evidence that this protein is required for the establishment of proviral DNA in the infected cell (5, 10, 11, 13) . Integrase has also been shown to be responsible for the generation of the proper terminal structure of the linear viral DNA required for integration in vivo (12) . These findings suggest an association between integrase and viral DNA in vivo; this report presents the first direct evidence for such an association.
The role of other viral proteins in the integration reaction remains unknown. Work presented here indicates that integrase may be the only viral protein needed for integration after viral DNA synthesis has occurred, as fully integrationcompetent complexes contained no other detectable viral proteins. Purified HIV-1 integrase protein has recently been shown to be sufficient for the in vitro integration of DNA molecules having ends resembling the termini of linear viral DNA (3). In addition, purified avian and murine retroviral integrase proteins are sufficient to catalyze the self-integration of oligonucleotides which mimic termini of viral DNA (4, 7) . These reports, combined with the work presented here, raise the possibility that fully integration-competent nucleoprotein complexes contain linear viral DNA and integrase as the sole viral components.
Nucleoprotein complexes of the murine leukemia virus can be immunoprecipitated from cytoplasmic extracts with antisera to the murine leukemia virus major capsid protein, indicating that this protein is a part of the murine preintegration complex in vivo (1). However, no HIV-1 p24 was detectable in gel filtration and gradient sedimentation fractions containing viral DNA by the methods used here. The presence of a small amount of viral p24 in the nucleoprotein complex undetectable by the methods used here may explain the discrepancy in the two findings. Alternatively, these findings may indicate that the structures of the preintegration complexes of these two retroviruses differ. The role of cellular factors in the in vitro integration reaction also remains unknown. Addition of the cytoplasmic extracts from uninfected cells to preintegration complexes purified by gel filtration had no effect on the integration reaction. This result does not preclude the involvement of host factors in the integration reaction, as cellular proteins may cofractionate with the preintegration complex and may indeed contribute to the structure of the complex. The presence of host proteins in the preintegration complex is currently under investigation.
